Where this LCD applies
Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.
Billing and coding article A56805: diagnoses and procedure codes
Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56805 (Billing and Coding: Magnetic Resonance Angiography (MRA)) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown. Each article below opens its complete covered and non-covered ICD-10-CM lists, by group and with the contractor's group instructions, and the LCD code lookup answers whether one diagnosis is covered for one procedure code in a given state.
Coverage is only half of the claim edit: when two of the listed procedure codes are billed on the same date, test the pair against the NCCI edits before relying on both being paid.
A56805: Billing and Coding: Magnetic Resonance Angiography (MRA) (Billing and Coding, effective 2025-10-01)
- Covered ICD-10-CM codes
- 999
- 4 groups
- Non-covered ICD-10-CM codes
- 0
- Procedure codes listed
- 22
- Full article
- cms.gov record
| ICD-10-CM | Description (FY2027) |
|---|---|
| A52.01 | Syphilitic aneurysm of aorta |
| A52.05 | Other cerebrovascular syphilis |
| A52.19 | Other symptomatic neurosyphilis |
| C00.0 | Malignant neoplasm of external upper lip |
| C00.1 | Malignant neoplasm of external lower lip |
| C00.2 | Malignant neoplasm of external lip, unspecified |
| C00.3 | Malignant neoplasm of upper lip, inner aspect |
| C00.4 | Malignant neoplasm of lower lip, inner aspect |
| C00.5 | Malignant neoplasm of lip, unspecified, inner aspect |
| C00.6 | Malignant neoplasm of commissure of lip, unspecified |
| C00.8 | Malignant neoplasm of overlapping sites of lip |
| C01 | Malignant neoplasm of base of tongue |
| C02.0 | Malignant neoplasm of dorsal surface of tongue |
| C02.1 | Malignant neoplasm of border of tongue |
| C02.2 | Malignant neoplasm of ventral surface of tongue |
| C02.3 | Malignant neoplasm of anterior two-thirds of tongue, part unspecified |
| C02.4 | Malignant neoplasm of lingual tonsil |
| C02.8 | Malignant neoplasm of overlapping sites of tongue |
| C02.9 | Malignant neoplasm of tongue, unspecified |
| C03.0 | Malignant neoplasm of upper gum |
| C03.1 | Malignant neoplasm of lower gum |
| C03.9 | Malignant neoplasm of gum, unspecified |
| C04.0 | Malignant neoplasm of anterior floor of mouth |
| C04.1 | Malignant neoplasm of lateral floor of mouth |
Procedure codes: 70544, 70545, 70546, 70547, 70548, 70549, 71555, 72198, 73725, 74185, C8900 (Magnetic resonance angiography with contrast, abdomen), C8901 (Magnetic resonance angiography without contrast, abdomen), C8902 (Magnetic resonance angiography without contrast followed by with contrast, abdomen), C8909 (Magnetic resonance angiography with contrast, chest (excluding myocardium)), C8910 (Magnetic resonance angiography without contrast, chest (excluding myocardium)), C8911 (Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)), C8912 (Magnetic resonance angiography with contrast, lower extremity), C8913 (Magnetic resonance angiography without contrast, lower extremity), C8914 (Magnetic resonance angiography without contrast followed by with contrast, lower extremity), C8918 (Magnetic resonance angiography with contrast, pelvis), C8919 (Magnetic resonance angiography without contrast, pelvis), C8920 (Magnetic resonance angiography without contrast followed by with contrast, pelvis).
Coverage indications, limitations and medical necessity
Compliance with the provisions in this policy may be monitored and addressed through post payment data analysis and subsequent medical review audits.
History/Background and/or General Information
Magnetic resonance angiography (MRA) is a non-invasive diagnostic test that is an application of magnetic resonance imaging (MRI). By analyzing the amount of energy released from tissues exposed to a strong magnetic field, MRA provides images of normal and diseased blood vessels as well as visualization and quantification of blood flow through these vessels.
Please refer to the National Coverage Determination for MRI and MRA documented in CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Part 4, Section 220.2 Magnetic Resonance Imaging (MRI) for coverage details.
COVERED INDICATIONS
I. HEAD AND NECK
Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.A.2 and 220.2.B.2 for coverage details and guidelines on the use of MRA of the head and neck.
MRA is appropriately used to verify the presence of a condition, suspected because of findings from another test (usually an imaging study). For example, a patient who presents with a transient ischemic attack (TIA) should not undergo MRA simply because he might have a lesion which is amenable to surgery. However, if that patient has a carotid bruit and is found by Doppler study to have carotid stenosis, an MRA may be appropriate to evaluate the stenotic section of artery for surgical intervention. Please note that the anticipated surgery may be a percutaneous procedure such as carotid angioplasty with stent insertion.
Another patient may present with a headache; it is not appropriate to proceed directly to MRA to rule out the possibility of an intracranial aneurysm. However, if that patient was found to have a clinically significant amount of blood in the cerebrospinal fluid, or the patient demonstrated signs and symptoms strongly suggesting an unruptured intracranial aneurysm, an MRA (or cerebral angiogram) may be appropriate.
An MRA is not considered medically reasonable and necessary for screening asymptomatic patients for intracranial aneurysms.
II. PERIPHERAL ARTERIES OF LOWER EXTREMITIES
Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.B.2.b for coverage details and guidelines on the use of MRA in the peripheral arteries of the lower extremities.
III. ABDOMEN AND PELVIS
Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.B.2.c for coverage details and guidelines on the use of MRA in the pre-operative evaluation of patients undergoing elective abdominal aortic aneurysm (AAA) repair and imaging of the renal arteries and aortoiliac arteries in the absence of AAA or aortic dissection.
An MRA of the abdomen for evaluation of possible renal artery stenosis would not be considered medically reasonable and necessary without some evidence consistent with renovascular hypertension. Such evidence might include:
• a history of early or late onset of hypertension, hypertension refractory to medication, or worsening renal function;
• the presence of a renal artery bruit;
• laboratory tests (elevated serum renins, increasing creatinine); or
• other radiologic tests (ultrasound, captopril scintigraphy, or other imaging showing small kidney or unequal kidney sizes).
IV. CHEST
Diagnosis of Pulmonary Embolism
Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.B.2.d.i for coverage details and guidelines on the use of MRA in the diagnosis of pulmonary embolism.
Evaluation of Thoracic Aortic Dissection and Aneurysm
Please refer to CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual , Chapter 1, Part 4, Section 220.2.B.2.d.ii for coverage details and guidelines on the evaluation of thoracic aortic dissection and aneurysm.
NOTE: This LCD does not address cardiac magnetic resonance imaging.
Notice: Services performed for any given diagnosis must meet all of the indications and limitations stated in this policy, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules.
The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in this LCD.
Summary of evidence (opening)
N/A
The contractor cites 2 sources in the bibliography; the full summary and analysis of evidence are in the CMS record.
Dates, lineage and related policies
- Original determination effective
- 2015-10-01
- Current revision effective
- 2020-07-01
- Last reviewed by the contractor
- 2018-05-07
- MCD version
- 72
- Derived from
- L31399
The contractor lists one National Coverage Determination as related: NCD 220.2 Magnetic Resonance Imaging. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.
Using this policy on a claim
Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line (the diagnosis coverage checker tests one code pair against every article that applies in a state), and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Novitas Solutions, Inc. hub lists every other active policy from the same contractor.
The same policy title at other contractors
Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.
For teams evaluating QuickIntell software
Where QuickIntell fits with this policy
If your team repeatedly reviews local coverage policies, explore QuickAuth for requirement checks, documentation and status tracking with staff oversight. Confirm the applicable policy, supported workflow and review responsibilities. Use QuickRCM to evaluate the separate claim and denial workflow.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
What does LCD L34865 cover?
Magnetic resonance angiography (MRA) is a non-invasive diagnostic test that is an application of magnetic resonance imaging (MRI). By analyzing the amount of energy released from tissues exposed to a strong magnetic field, MRA provides images of normal and diseased blood vessels as well as visualization and quantification of blood flow through these vessels. The full 684-word policy text is reproduced below from the Medicare Coverage Database export of November 12, 2026.
Which states does LCD L34865 apply to?
Novitas Solutions, Inc. applies it to Medicare claims in 11 states plus DC: AR, CO, DC, DE, LA, MD, MS, NJ, NM, OK, PA, TX. It binds only that contractor; 3 other contractor versions of this title govern other jurisdictions, and elsewhere the same service is judged under the local contractor's own policy or, where none exists, claim by claim.
Which diagnosis codes support medical necessity under LCD L34865?
The companion billing and coding article A56805 lists 999 ICD-10-CM codes in 4 groups that support medical necessity; the first 24 appear on this page, where the complete list opens by group with the contractor's group instructions.
How do I appeal a denial under LCD L34865?
A denial under LCD L34865 carries claim adjustment reason code 50 with remark code N115. Compare the documented indication with the policy's covered indications and article A56805's 999 covered diagnosis codes, then file a redetermination with Novitas Solutions, Inc. within 120 days, record attached. If the service falls outside the policy, bill the patient only with a valid Advance Beneficiary Notice signed before the service.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database, current LCD exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file lcd.csvSHA-256 2e0eda3351aa3d47…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- ICD-10-CM FY2027 code descriptionsVersion FY2027 · effective 2026-10-01 · file icd10cm_codes_2027.txtSHA-256 3c0583a38ee0e848…
Disclaimer
The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.